FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/18/2026
Back to search
Official data from USPTO
DEBIOPHARM WE DEVELOP FOR PATIENTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/19/2026
Trademark type
Combined
Nice classes
35, 42, 44
Filing date
10/19/2023
Registration date
11/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/18/2025
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
ELTON, DAVID JONATHAN
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "DEBIOPHARM" above the wording "WE DEVELOP FOR PATIENTS" with all wording in black stylized font to the right of a red circle with a white dot inside.
Holders and representatives
Holders
Après-demain SA
Representatives
Duane M. Byers Nixon & Vanderhye PC
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Outsource service provider in the field of administrative business management
Class 42
Scientific and technological servicesscientific researchdesignanalysis in the fields of biologymedicine and pharmaceuticalsresearch and design relating thereto; industrial analysisanalysis of industrial biopharmaceuticals; industrial research services in the fields of biologymedicine and pharmaceuticals; design and development of computer hardware and software
Class 44
Medical services; Hygienic and beauty care for human beings
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2026
FIMP
FINAL DISPOSITION PROCESSED
06/03/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/18/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/18/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/30/2025
PUBO
PUBLISHED FOR OPPOSITION
09/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/28/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/22/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/06/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/06/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/28/2025
GNFR
FINAL REFUSAL E-MAILED
02/28/2025
CNFR
FINAL REFUSAL WRITTEN
02/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2024
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
12/10/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/27/2024
RFNT
REFUSAL PROCESSED BY IB
07/15/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/24/2024
RFRR
REFUSAL PROCESSED BY MPU
06/24/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/07/2024
CNRT
NON-FINAL ACTION WRITTEN
05/23/2024
DOCK
ASSIGNED TO EXAMINER
05/18/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/07/2024
Continuous trademark protection
Get notified about every new filing that threatens DEBIOPHARM WE DEVELOP FOR PATIENTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.